All 1 Debates between Lord Evans of Rainow and Lord McFall of Alcluith

Secondary Metastatic Breast Cancer

Debate between Lord Evans of Rainow and Lord McFall of Alcluith
Tuesday 9th May 2023

(1 year, 6 months ago)

Lords Chamber
Read Full debate Read Hansard Text
Lord Evans of Rainow Portrait Lord Evans of Rainow (Con)
- View Speech - Hansard - -

My Lords, the Government are committed to supporting timely access for NHS patients to clinically effective and cost-effective new drugs, including for breast cancer. NICE is able to recommend the vast majority of cancer medicines that it appraises. It has also made positive recommendations in all 19 of its appraisals of breast cancer treatments since 2016. This track record has been made possible by the cancer drugs fund, which has benefited more than 88,000 patients as of March 2023, with 102 medicines treating 241 different cancers having received funding. The CDF has enabled breast cancer patients to access promising new medicines such as Enhertu and Ibrance, while allowing for the collection of further data on their clinical and cost effectiveness.

Lord McFall of Alcluith Portrait The Lord Speaker (Lord McFall of Alcluith)
- Hansard - - - Excerpts

My Lords, the noble Baroness, Lady Brinton, is taking part remotely.

Baroness Brinton Portrait Baroness Brinton (LD) [V]
- View Speech - Hansard - - - Excerpts

My Lords, while it is good to hear about the audit, five months ago respected oncologist Professor Carlo Palmieri from Liverpool University estimated that the number of cases of metastatic breast cancer in England increased from more than 48,000 in 2019 to more than 57,000 in 2020-21, resulting in an increased need for clinical activity and work. What planning, design and recommissioning of appropriate cancer services have been undertaken by the NHS? Have the Government provided the extra resources needed to deliver clinical services to these patients this year?